BridgeMD
New treatment option for Motion Sickness
Official title Evaluation of a Device to Reduce Motion Sickness and Spatial Disorientation
ClinicalTrials.gov ID: NCT06892340
What this study is testing
- What it's testing
- The purpose of this research study is to learn how a wearable nerve stimulation device, the Spark Biomedical's Sparrow Ascent System™, impacts the development of spatial disorientation and/or motion sickness in a healthy population. Spatial disorientation is when there is a "mismatch" between where a person is, and where the sense organs in their body tell them where they are.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50. Healthy volunteers may be eligible.
You may be able to join if
- 1. Healthy males and non-pregnant females between the ages of 18-50 who do not experience symptoms of motion sickness.
- Participants who are English speaking.
- Participants who are able to read and understand study procedures in order to provide informed consent.
You likely can't join if
- Females who are pregnant
- Cardiac pathology (congestive heart failure, history of myocardial infarction, cardiac stent placement, pacemaker placement, heart surgery)
- Hypertension requiring daily medication
- Active vestibular disease to include Meniere's disease, migraine associated vertigo, benign paroxysmal positional vertigo, labyrinthitis
- Neck pain or spinal pathology
- Medications impacting cardiac, vestibular, or neurologic function
See the full eligibility criteria
- 1. Healthy males and non-pregnant females between the ages of 18-50 who do not experience symptoms of motion sickness.
- Participants who are English speaking.
- Participants who are able to read and understand study procedures in order to provide informed consent.
- Females who are pregnant
- Cardiac pathology (congestive heart failure, history of myocardial infarction, cardiac stent placement, pacemaker placement, heart surgery)
- Hypertension requiring daily medication
- Active vestibular disease to include Meniere's disease, migraine associated vertigo, benign paroxysmal positional vertigo, labyrinthitis
- Neck pain or spinal pathology
- Medications impacting cardiac, vestibular, or neurologic function
- Recently ill or hospitalized within 30 days
- Pilots and individuals formally desensitized to motion sickness
- Use of vestibular suppressing medications or drugs within 24 hours of the study (antihistamines, histamine-1 receptor agonists, benzodiazepines, anticholinergics, dopamine receptor agonists, alcohol, marijuana, tobacco...
- Participant has a history of epileptic seizures
- Participant has a history of neurological diseases or traumatic brain injury
- Abnormal vital signs obtained during pre-experimentation phase:
- Heart Rate \>100 or \<50
- Systolic blood pressure \>150 or \<90
- Respiratory rate \>24 or \<8 13. Participant has presence of devices, e.g., pacemakers, cochlear prosthesis, neurostimulators 14. Participant has abnormal ear anatomy or ear infection present 15. Participant has any...
The study team makes the final eligibility decision.
Where it's taking place
- San Antonio, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include San Antonio, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.